Annexin A2 heterotetramer: Structure and function

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 6259-6305

  Bharadwaj, Alamelu ^a   Bydoun, Moamen ^b   Holloway, Ryan ^b   Waisman, David ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Annexin A2; Anti phospholipid syndrome; Cancer; Fibrinolysis; Phospholipid binding; Plasmin; Plasminogen receptor; Redox regulation; S100A10

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ARSENIC TRIOXIDE; CALCIUM BINDING PROTEIN; DOXORUBICIN; F ACTIN; FASCIN; GEMCITABINE; ION CHANNEL; LIPOCORTIN 2; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PACLITAXEL; PHOSPHOLIPID BINDING PROTEIN; PROTEIN S 100; PROTEIN S100A10; RETINOIC ACID; TETRAMER; TM 601; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; BREAST CANCER; CANCER INHIBITION; CANCER PROGNOSIS; CELL MEMBRANE TRANSPORT; CELL METABOLISM; CELL POLARITY; COLORECTAL CARCINOMA; DRUG PROTEIN BINDING; DRUG TARGETING; ENDOCYTOSIS; EXOCYTOSIS; FIBRINOLYSIS; HEAD AND NECK CANCER; HUMAN; INFLAMMATORY DISEASE; ION CONDUCTANCE; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG METASTASIS; METASTASIS FREE SURVIVAL; NONHUMAN; PANCREAS ADENOCARCINOMA; PROMYELOCYTIC LEUKEMIA; PROSTATE CANCER; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; RNA BINDING; TRANSCRIPTION REGULATION;

EID: 84875514370     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14036259     Document Type: Review

References (237)

1. Clark, G.B.; Morgan, R.O.; Fernandez, M.P.; Roux, S.J. Evolutionary adaptation of plant annexins has diversified their molecular structures, interactions and functional roles. New Phytol. 2012, 196, 695-712.
2. 2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 2005, 6, 449-461.
3. Gerke, V.; Moss, S.E. Annexins: From structure to function. Physiol. Rev. 2002, 82, 331-371.
4. Moss, S.E.; Morgan, R.O. The annexins. Genome Biol. 2004, 5, 219.
5. Seaton, B.A.; Dedman, J.R. Annexins. Biometals 1998, 11, 399-404.
6. Rescher, U.; Gerke, V. Annexins-Unique membrane binding proteins with diverse functions. J. Cell Sci. 2004, 117, 2631-2639.
7. Creutz, C.E.; Pazoles, C.J.; Pollard, H.B. Identification and purification of an adrenal medullary protein (synexin) that causes calcium-dependent aggregation of isolated chromaffin granules. J. Biol. Chem. 1978, 253, 2858-2866.
8. Luecke, H.; Chang, B.T.; Mailliard, W.S.; Schlaepfer, D.D.; Haigler, H.T. Crystal structure of the annexin XII hexamer and implications for bilayer insertion. Nature 1995, 378, 512-515.
9. Domon, M.; Nasir, M.N.; Matar, G.; Pikula, S.; Besson, F.; Bandorowicz-Pikula, J. Annexins as organizers of cholesterol-and sphingomyelin-enriched membrane microdomains in Niemann-Pick type C disease. Cell Mol. Life Sci. 2012, 69, 1773-1785.
10. Erikson, E.; Erikson, R.L. Identification of a cellular protein substrate phosphorylated by the avian sarcoma virus-transforming gene product. Cell 1980, 21, 829-836.
11. Waisman, D.M. Annexin II tetramer: Structure and function. Mol. Cell Biochem. 1995, 149-150, 301-322.
12. Gladwin, M.T.; Yao, X.L.; Cowan, M.; Huang, X.L.; Schneider, R.; Grant, L.R.; Logun, C.; Shelhamer, J.H. Retinoic acid reduces p11 protein levels in bronchial epithelial cells by a posttranslational mechanism. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279, L1103-L1109.
13. He, K.L.; Deora, A.B.; Xiong, H.; Ling, Q.; Weksler, B.B.; Niesvizky, R.; Hajjar, K.A. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J. Biol. Chem. 2008, 283, 19192-19200.
14. Hou, Y.; Yang, L.; Mou, M.; Zhang, A.; Pan, N.; Qiang, R.; Wei, L.; Zhang, N. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Cancer Invest. 2008, 26, 809-815.
15. Puisieux, A.; Ji, J.; Ozturk, M. Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms. Biochem. J. 1996, 313 (Pt. 1), 51-55.
16. Yang, X.; Popescu, N.C.; Zimonjic, D.B. DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism. Cancer Res. 2011, 71, 2916-2925.
17. Zhang, J.; Guo, B.; Zhang, Y.; Cao, J.; Chen, T. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion. Saudi Med. J. 2010, 31, 374-381.
18. Madureira, P.A.; Surette, A.P.; Phipps, K.D.; Taboski, M.A.; Miller, V.A.; Waisman, D.M. The role of the annexin A2 heterotetramer in vascular fibrinolysis. Blood 2011, 118, 4789-4797.
19. Madureira, P.A.; O'Connell, P.A.; Surette, A.P.; Miller, V.A.; Waisman, D.M. The biochemistry and regulation of S100A10: A multifunctional plasminogen receptor involved in oncogenesis. J. Biomed. Biotechnol. 2012, 2012, 353687.
20. Phipps, K.D.; Surette, A.P.; O'Connell, P.A.; Waisman, D.M. Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites. Cancer Res. 2011, 71, 6676-6683.
21. Kwon, M.; MacLeod, T.J.; Zhang, Y.; Waisman, D.M. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front. Biosci. 2005, 10, 300-325.
22. Roth, D.; Morgan, A.; Burgoyne, R.D. Identification of a key domain in annexin and 14-3-3 proteins that stimulate calcium-dependent exocytosis in permeabilized adrenal chromaffin cells. FEBS Lett. 1993, 320, 207-210.
23. Liemann, S.; Huber, R. Three-dimensional structure of annexins. Cell Mol. Life Sci. 1997, 53, 516-521.
24. Becker, T.; Weber, K.; Johnsson, N. Protein-protein recognition via short amphiphilic helices; a mutational analysis of the binding site of annexin II for p11. EMBO J. 1990, 9, 4207-4213.
25. Johnsson, N.; Marriott, G.; Weber, K. p36, the major cytoplasmic substrate of src tyrosine protein kinase, binds to its p11 regulatory subunit via a short amino-terminal amphiphatic helix. EMBO J. 1988, 7, 2435-2442.
26. Rety, S.; Sopkova, J.; Renouard, M.; Osterloh, D.; Gerke, V.; Tabaries, S.; Russo-Marie, F.; Lewit-Bentley, A. The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat. Struct. Biol. 1999, 6, 89-95.
27. Rezvanpour, A.; Shaw, G.S. Unique S100 target protein interactions. Gen. Physiol. Biophys. 2009, 28(Focus Issue), F39-F46.
28. Lambert, O.; Gerke, V.; Bader, M.F.; Porte, F.; Brisson, A. Structural analysis of junctions formed between lipid membranes and several annexins by cryo-electron microscopy. J. Mol. Biol. 1997, 272, 42-55.
29. Menke, M.; Ross, M.; Gerke, V.; Steinem, C. The molecular arrangement of membrane-bound annexin A2-S100A10 tetramer as revealed by scanning force microscopy. Chembiochem 2004, 5, 1003-1006.
30. Schulz, D.M.; Kalkhof, S.; Schmidt, A.; Ihling, C.; Stingl, C.; Mechtler, K.; Zschornig, O.; Sinz, A. Annexin A2/P11 interaction: New insights into annexin A2 tetramer structure by chemical crosslinking, high-resolution mass spectrometry, and computational modeling. Proteins 2007, 69, 254-269.
31. Glenney, J.R., Jr.; Tack, B.F. Amino-terminal sequence of p36 and associated p10: Identification of the site of tyrosine phosphorylation and homology with S-100. Proc. Natl. Acad. Sci. USA 1985, 82, 7884-7888.
32. Kwon, M.; Yoon, C.S.; Jeong, W.; Rhee, S.G.; Waisman, D.M. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin. J. Biol. Chem. 2005, 280, 23584-23592.
33. Eberhard, D.A.; Karns, L.R.; VandenBerg, S.R.; Creutz, C.E. Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J. Cell Sci. 2001, 114, 3155-3166.
34. 2+)-induced conformational changes. Science 1993, 261, 1321-1324.
35. 2+)-binding sites in human annexin II. Eur. J. Biochem. 1992, 207, 923-930.
36. 2+)-binding sites. Biochem. J. 1994, 298 Pt. 3, 553-559.
37. Sopkova, J.; Renouard, M.; Lewit-Bentley, A. The crystal structure of a new high-calcium form of annexin V. J. Mol. Biol. 1993, 234, 816-825.
38. Weng, X.; Luecke, H.; Song, I.S.; Kang, D.S.; Kim, S.H.; Huber, R. Crystal structure of human annexin I at 2.5 A resolution. Protein Sci. 1993, 2, 448-458.
39. Shao, C.; Zhang, F.; Kemp, M.M.; Linhardt, R.J.; Waisman, D.M.; Head, J.F.; Seaton, B.A. Crystallographic analysis of calcium-dependent heparin binding to annexin A2. J. Biol. Chem. 2006, 281, 31689-31695.
40. 2+-binding sites of annexin II tetramer. J. Biol. Chem. 2000, 275, 38877-38884.
41. Blackwood, R.A.; Ernst, J.D. Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem. J. 1990, 266, 195-200.
42. Menke, M.; Gerke, V.; Steinem, C. Phosphatidylserine membrane domain clustering induced by annexin A2/S100A10 heterotetramer. Biochemistry 2005, 44, 15296-15303.
43. Babiychuk, E.B.; Draeger, A. Annexins in cell membrane dynamics. Ca(2+)-regulated association of lipid microdomains. J. Cell Biol. 2000, 150, 1113-1124.
44. Oliferenko, S.; Paiha, K.; Harder, T.; Gerke, V.; Schwarzler, C.; Schwarz, H.; Beug, H.; Gunthert, U.; Huber, L.A. Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. J. Cell Biol. 1999, 146, 843-854.
45. Benaud, C.; Gentil, B.J.; Assard, N.; Court, M.; Garin, J.; Delphin, C.; Baudier, J. AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J. Cell Biol. 2004, 164, 133-144.
46. Harder, T.; Kellner, R.; Parton, R.G.; Gruenberg, J. Specific release of membrane-bound annexin II and cortical cytoskeletal elements by sequestration of membrane cholesterol. Mol. Biol. Cell 1997, 8, 533-545.
47. Merrifield, C.J.; Rescher, U.; Almers, W.; Proust, J.; Gerke, V.; Sechi, A.S.; Moss, S.E. Annexin 2 has an essential role in actin-based macropinocytic rocketing. Curr. Biol. 2001, 11, 1136-1141.
48. Zobiack, N.; Rescher, U.; Laarmann, S.; Michgehl, S.; Schmidt, M.A.; Gerke, V. Cell-surface attachment of pedestal-forming enteropathogenic E. coli induces a clustering of raft components and a recruitment of annexin 2. J. Cell Sci. 2002, 115, 91-98.
49. Gokhale, N.A.; Abraham, A.; Digman, M.A.; Gratton, E.; Cho, W. Phosphoinositide specificity of and mechanism of lipid domain formation by annexin A2-p11 heterotetramer. J. Biol. Chem. 2005, 280, 42831-42840.
50. Hayes, M.J.; Merrifield, C.J.; Shao, D.; Ayala-Sanmartin, J.; Schorey, C.D.; Levine, T.P.; Proust, J.; Curran, J.; Bailly, M.; Moss, S.E. Annexin 2 binding to phosphatidylinositol 4,5-bisphosphate on endocytic vesicles is regulated by the stress response pathway. J. Biol. Chem. 2004, 279, 14157-14164.
51. Ayala-Sanmartin, J.; Henry, J.P.; Pradel, L.A. Cholesterol regulates membrane binding and aggregation by annexin 2 at submicromolar Ca(2+) concentration. Biochim. Biophys. Acta 2001, 1510, 18-28.
52. Mayran, N.; Parton, R.G.; Gruenberg, J. Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J. 2003, 22, 3242-3253.
53. Pike, L.J.; Casey, L. Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J. Biol. Chem. 1996, 271, 26453-26456.
54. Campos, B.; Mo, Y.D.; Mealy, T.R.; Li, C.W.; Swairjo, M.A.; Balch, C.; Head, J.F.; Retzinger, G.; Dedman, J.R.; Seaton, B.A. Mutational and crystallographic analyses of interfacial residues in annexin V suggest direct interactions with phospholipid membrane components. Biochemistry 1998, 37, 8004-8010.
55. Janmey, P.A.; Lamb, J.; Allen, P.G.; Matsudaira, P.T. Phosphoinositide-binding peptides derived from the sequences of gelsolin and villin. J. Biol. Chem. 1992, 267, 11818-11823.
56. Keutzer, J.C.; Hirschhorn, R.R. The growth-regulated gene 1B6 is identified as the heavy chain of calpactin I. Exp. Cell Res. 1990, 188, 153-159.
57. Ozaki, T.; Sakiyama, S. Molecular cloning of rat calpactin I heavy-chain cDNA whose expression is induced in v-src-transformed rat culture cell lines. Oncogene 1993, 8, 1707-1710.
58. Braselmann, S.; Bergers, G.; Wrighton, C.; Graninger, P.; Superti-Furga, G.; Busslinger, M. Identification of Fos target genes by the use of selective induction systems. J. Cell Sci. Suppl. 1992, 16, 97-109.
59. Genetos, D.C.; Wong, A.; Watari, S.; Yellowley, C.E. Hypoxia increases Annexin A2 expression in osteoblastic cells via VEGF and ERK. Bone 2010, 47, 1013-1019.
60. Zhao, S.; Huang, L.; Wu, J.; Zhang, Y.; Pan, D.; Liu, X. Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy. Mol. Vis. 2009, 15, 1231-1242.
61. Konig, J.; Prenen, J.; Nilius, B.; Gerke, V. The annexin II-p11 complex is involved in regulated exocytosis in bovine pulmonary artery endothelial cells. J. Biol. Chem. 1998, 273, 19679-19684.
62. Fey, M.F.; Moffat, G.J.; Vik, D.P.; Meisenhelder, J.; Saris, C.J.; Hunter, T.; Tack, B.F. Complete structure of the murine p36 (annexin II) gene. Identification of mRNAs for both the murine and the human gene with alternatively spliced 5' noncoding exons. Biochim. Biophys. Acta 1996, 1306, 160-170.
63. Upton, A.L.; Moss, S.E. Molecular cloning of a novel N-terminal variant of annexin II from rat basophilic leukaemia cells. Biochem. J. 1994, 302 (Pt. 2), 425-428.
64. Hollas, H.; Aukrust, I.; Grimmer, S.; Strand, E.; Flatmark, T.; Vedeler, A. Annexin A2 recognises a specific region in the 3'-UTR of its cognate messenger RNA. Biochim. Biophys. Acta 2006, 1763, 1325-1334.
65. Hubaishy, I.; Jones, P.G.; Bjorge, J.; Bellagamba, C.; Fitzpatrick, S.; Fujita, D.J.; Waisman, D.M. Modulation of annexin II tetramer by tyrosine phosphorylation. Biochemistry 1995, 34, 14527-14534.
66. Lauvrak, S.U.; Hollas, H.; Doskeland, A.P.; Aukrust, I.; Flatmark, T.; Vedeler, A. Ubiquitinated annexin A2 is enriched in the cytoskeleton fraction. FEBS Lett. 2005, 579, 203-206.
67. Deng, S.; Jing, B.; Xing, T.; Hou, L.; Yang, Z. Overexpression of annexin A2 is associated with abnormal ubiquitination in breast cancer. Genomics Proteomics Bioinforma. 2012, 10, 153-157.
68. Giuliani, F.; Grieve, A.; Rabouille, C. Unconventional secretion: A stress on GRASP. Curr. Opin. Cell Biol. 2011, 23, 498-504.
69. Nickel, W. The unconventional secretory machinery of fibroblast growth factor 2. Traffic 2011, 12, 799-805.
70. Temmerman, K.; Ebert, A.D.; Muller, H.M.; Sinning, I.; Tews, I.; Nickel, W. A direct role for phosphatidylinositol-4,5-bisphosphate in unconventional secretion of fibroblast growth factor 2. Traffic 2008, 9, 1204-1217.
71. Deora, A.B.; Kreitzer, G.; Jacovina, A.T.; Hajjar, K.A. An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J. Biol. Chem. 2004, 279, 43411-43418.
72. Valapala, M.; Vishwanatha, J.K. Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. J. Biol. Chem. 2011, 286, 30911-30925.
73. Danielsen, E.M.; van Deurs, B.; Hansen, G.H. "Nonclassical" secretion of annexin A2 to the lumenal side of the enterocyte brush border membrane. Biochemistry 2003, 42, 14670-14676.
74. Delouche, B.; Pradel, L.A.; Henry, J.P. Phosphorylation by protein kinase C of annexin 2 in chromaffin cells stimulated by nicotine. J. Neurochem. 1997, 68, 1720-1727.
75. Sarafian, T.; Pradel, L.A.; Henry, J.P.; Aunis, D.; Bader, M.F. The participation of annexin II (calpactin I) in calcium-evoked exocytosis requires protein kinase C. J. Cell Biol. 1991, 114, 1135-1147.
76. Cheng, Y.S.; Chen, L.B. Detection of phosphotyrosine-containing 34,000-dalton protein in the framework of cells transformed with Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 1981, 78, 2388-2392.
77. Radke, K.; Gilmore, T.; Martin, G.S. Transformation by Rous sarcoma virus: A cellular substrate for transformation-specific protein phosphorylation contains phosphotyrosine. Cell 1980, 21, 821-828.
78. Johnstone, S.A.; Hubaishy, I.; Waisman, D.M. Phosphorylation of annexin II tetramer by protein kinase C inhibits aggregation of lipid vesicles by the protein. J. Biol. Chem. 1992, 267, 25976-25981.
79. Powell, M.A.; Glenney, J.R. Regulation of calpactin I phospholipid binding by calpactin I light-chain binding and phosphorylation by p60v-src. Biochem. J. 1987, 247, 321-328.
80. Jost, M.; Gerke, V. Mapping of a regulatory important site for protein kinase C phosphorylation in the N-terminal domain of annexin II. Biochim. Biophys. Acta 1996, 1313, 283-289.
81. Regnouf, F.; Sagot, I.; Delouche, B.; Devilliers, G.; Cartaud, J.; Henry, J.P.; Pradel, L.A. "In vitro" phosphorylation of annexin 2 heterotetramer by protein kinase C. Comparative properties of the unphosphorylated and phosphorylated annexin 2 on the aggregation and fusion of chromaffin granule membranes. J. Biol. Chem. 1995, 270, 27143-27150.
82. De Graauw, M.; Tijdens, I.; Smeets, M.B.; Hensbergen, P.J.; Deelder, A.M.; van de Water, B. Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin Activation. Mol. Cell Biol. 2008, 28, 1029-1040.
83. Zheng, L.; Foley, K.; Huang, L.; Leubner, A.; Mo, G.; Olino, K.; Edil, B.H.; Mizuma, M.; Sharma, R.; Le, D.T.; et al. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One 2011, 6, e19390.
84. Liu, J.; Rothermund, C.A.; Ayala-Sanmartin, J.; Vishwanatha, J.K. Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II. BMC Biochem. 2003, 4, 10.
85. Karasik, A.; Pepinsky, R.B.; Shoelson, S.E.; Kahn, C.R. Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver. J. Biol. Chem. 1988, 263, 11862-11867.
86. Biener, Y.; Feinstein, R.; Mayak, M.; Kaburagi, Y.; Kadowaki, T.; Zick, Y. Annexin II is a novel player in insulin signal transduction. Possible association between annexin II phosphorylation and insulin receptor internalization. J. Biol. Chem. 1996, 271, 29489-29496.
87. Rescher, U.; Ludwig, C.; Konietzko, V.; Kharitonenkov, A.; Gerke, V. Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion. J. Cell Sci. 2008, 121, 2177-2185.
88. Jones, D.P. Redox sensing: Orthogonal control in cell cycle and apoptosis signalling. J. Intern. Med. 2010, 268, 432-448.
89. 2, a necessary evil for cell signaling. Science 2006, 312, 1882-1883.
90. Veal, E.A.; Day, A.M.; Morgan, B.A. Hydrogen peroxide sensing and signaling. Mol. Cell 2007, 26, 1-14.
91. Wang, Y.; Yang, J.; Yi, J. Redox sensing by proteins: Oxidative modifications on cysteines and the consequent events. Antioxid. Redox Signal. 2012, 16, 649-657.
92. Brandes, N.; Schmitt, S.; Jakob, U. Thiol-based redox switches in eukaryotic proteins. Antioxid. Redox Signal. 2009, 11, 997-1014.
93. Burger, A.; Berendes, R.; Liemann, S.; Benz, J.; Hofmann, A.; Gottig, P.; Huber, R.; Gerke, V.; Thiel, C.; Romisch, J.; et al. The crystal structure and ion channel activity of human annexin II, a peripheral membrane protein. J. Mol. Biol. 1996, 257, 839-847.
94. Kwon, M.; Caplan, J.F.; Filipenko, N.R.; Choi, K.S.; Fitzpatrick, S.L.; Zhang, L.; Waisman, D.M. Identification of annexin II heterotetramer as a plasmin reductase. J. Biol. Chem. 2002, 277, 10903-10911.
95. Sullivan, D.M.; Wehr, N.B.; Fergusson, M.M.; Levine, R.L.; Finkel, T. Identification of oxidant-sensitive proteins: TNF-alpha induces protein glutathiolation. Biochemistry 2000, 39, 11121-11128.
96. Rowan, W.H., 3rd; Sun, P.; Liu, L. Nitration of annexin II tetramer. Biochemistry 2002, 41, 1409-1420.
97. Singh, T.K.; Liu, L. Modification of cysteine residues by N-ethylmaleimide inhibits annexin II tetramer mediated liposome aggregation. Arch. Biochem. Biophys. 2000, 381, 235-240.
98. Caplan, J.F.; Filipenko, N.R.; Fitzpatrick, S.L.; Waisman, D.M. Regulation of annexin A2 by reversible glutathionylation. J. Biol. Chem. 2004, 279, 7740-7750.
99. Madureira, P.A.; Hill, R.; Miller, V.A.; Giacomantonio, C.; Lee, P.W.; Waisman, D.M. Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. Oncotarget 2011, 2, 1075-1093.
100. Chuthapisith, S.; Bean, B.E.; Cowley, G.; Eremin, J.M.; Samphao, S.; Layfield, R.; Kerr, I.D.; Wiseman, J.; El-Sheemy, M.; Sreenivasan, T.; et al. Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. Eur. J. Cancer 2009, 45, 1274-1281.
101. Arrigo, A.P.; Darlix, J.L.; Spahr, P.F. A cellular protein phosphorylated by the avian sarcoma virus transforming gene product is associated with ribonucleoprotein particles. EMBO J. 1983, 2, 309-315.
102. Vishwanatha, J.K.; Jindal, H.K.; Davis, R.G. The role of primer recognition proteins in DNA replication: Association with nuclear matrix in HeLa cells. J. Cell Sci. 1992, 101 (Pt. 1), 25-34.
103. Filipenko, N.R.; MacLeod, T.J.; Yoon, C.S.; Waisman, D.M. Annexin A2 is a novel RNA-binding protein. J. Biol. Chem. 2004, 279, 8723-8731.
104. Jindal, H.K.; Chaney, W.G.; Anderson, C.W.; Davis, R.G.; Vishwanatha, J.K. The protein-tyrosine kinase substrate, calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase alpha. J. Biol. Chem. 1991, 266, 5169-5176.
105. Madureira, P.A.; Hill, R.; Lee, P.W.; Waisman, D.M. Genotoxic agents promote the nuclear accumulation of annexin A2: Role of annexin A2 in mitigating DNA damage. PLoS One 2012, 7, e50591.
106. Waters, K.M.; Stenoien, D.L.; Sowa, M.B.; von Neubeck, C.H.; Chrisler, W.B.; Tan, R.; Sontag, R.L.; Weber, T.J. Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate. Radiat. Res. 2012, 179, 53-61.
107. Gerke, V.; Weber, K. Identity of p36K phosphorylated upon Rous sarcoma virus transformation with a protein purified from brush borders; calcium-dependent binding to non-erythroid spectrin and F-actin. EMBO J. 1984, 3, 227-233.
108. 2+-dependent manner. Proc. Natl. Acad. Sci. USA 1986, 83, 4258-4262.
109. Ikebuchi, N.W.; Waisman, D.M. Calcium-dependent regulation of actin filament bundling by lipocortin-85. J. Biol. Chem. 1990, 265, 3392-3400.
110. Jones, P.G.; Moore, G.J.; Waisman, D.M. A nonapeptide to the putative F-actin binding site of annexin-II tetramer inhibits its calcium-dependent activation of actin filament bundling. J. Biol. Chem. 1992, 267, 13993-13997.
111. Filipenko, N.R.; Waisman, D.M. The C terminus of annexin II mediates binding to F-actin. J. Biol. Chem. 2001, 276, 5310-5315.
112. Hayes, M.J.; Shao, D.; Bailly, M.; Moss, S.E. Regulation of actin dynamics by annexin 2. EMBO J. 2006, 25, 1816-1826.
113. Sakai, E.; Miyamoto, H.; Okamoto, K.; Kato, Y.; Yamamoto, K.; Sakai, H. Characterization of phagosomal subpopulations along endocytic routes in osteoclasts and macrophages. J. Biochem. 2001, 130, 823-831.
114. Higgs, H.N.; Pollard, T.D. Regulation of actin filament network formation through ARP2/3 complex: Activation by a diverse array of proteins. Annu. Rev. Biochem. 2001, 70, 649-676.
115. Hansen, M.D.; Ehrlich, J.S.; Nelson, W.J. Molecular mechanism for orienting membrane and actin dynamics to nascent cell-cell contacts in epithelial cells. J. Biol. Chem. 2002, 277, 45371-45376.
116. Jacob, R.; Heine, M.; Eikemeyer, J.; Frerker, N.; Zimmer, K.P.; Rescher, U.; Gerke, V.; Naim, H.Y. Annexin II is required for apical transport in polarized epithelial cells. J. Biol. Chem. 2004, 279, 3680-3684.
117. Ali, S.M.; Burgoyne, R.D. The stimulatory effect of calpactin (annexin II) on calcium-dependent exocytosis in chromaffin cells: Requirement for both the N-terminal and core domains of p36 and ATP. Cell. Signal. 1990, 2, 265-276.
118. Ali, S.M.; Geisow, M.J.; Burgoyne, R.D. A role for calpactin in calcium-dependent exocytosis in adrenal chromaffin cells. Nature 1989, 340, 313-315.
119. Graham, M.E.; Gerke, V.; Burgoyne, R.D. Modification of annexin II expression in PC12 cell lines does not affect Ca(2+)-dependent exocytosis. Mol. Biol. Cell 1997, 8, 431-442.
120. Chasserot-Golaz, S.; Vitale, N.; Sagot, I.; Delouche, B.; Dirrig, S.; Pradel, L.A.; Henry, J.P.; Aunis, D.; Bader, M.F. Annexin II in exocytosis: Catecholamine secretion requires the translocation of p36 to the subplasmalemmal region in chromaffin cells. J. Cell Biol. 1996, 133, 1217-1236.
121. Chasserot-Golaz, S.; Vitale, N.; Umbrecht-Jenck, E.; Knight, D.; Gerke, V.; Bader, M.F. Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles. Mol. Biol. Cell 2005, 16, 1108-1119.
122. Martin, T.F.; Loyet, K.M.; Barry, V.A.; Kowalchyk, J.A. The role of PtdIns(4,5)P2 in exocytotic membrane fusion. Biochem. Soc. Trans. 1997, 25, 1137-1141.
123. Emans, N.; Gorvel, J.P.; Walter, C.; Gerke, V.; Kellner, R.; Griffiths, G.; Gruenberg, J. Annexin II is a major component of fusogenic endosomal vesicles. J. Cell Biol. 1993, 120, 1357-1369.
124. Creutz, C.E.; Snyder, S.L. Interactions of annexins with the mu subunits of the clathrin assembly proteins. Biochemistry 2005, 44, 13795-13806.
125. Urbanska, A.; Sadowski, L.; Kalaidzidis, Y.; Miaczynska, M. Biochemical characterization of APPL endosomes: The role of annexin A2 in APPL membrane recruitment. Traffic 2011, 12, 1227-1241.
126. Bucci, C.; Parton, R.G.; Mather, I.H.; Stunnenberg, H.; Simons, K.; Hoflack, B.; Zerial, M. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 1992, 70, 715-728.
127. Denzer, K.; Kleijmeer, M.J.; Heijnen, H.F.; Stoorvogel, W.; Geuze, H.J. Exosome: From internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 2000, 113 Pt. 19, 3365-3374.
128. Thery, C.; Zitvogel, L.; Amigorena, S. Exosomes: Composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2, 569-579.
129. Fang, Y.T.; Lin, C.F.; Wang, C.Y.; Anderson, R.; Lin, Y.S. Interferon-gamma stimulates p11-dependent surface expression of annexin A2 in lung epithelial cells to enhance phagocytosis. J. Cell Physiol. 2012, 227, 2775-2787.
130. Yang, C.; Robbins, P.D. The roles of tumor-derived exosomes in cancer pathogenesis. Clin. Dev. Immunol. 2011, 2011, 842849.
131. Mears, R.; Craven, R.A.; Hanrahan, S.; Totty, N.; Upton, C.; Young, S.L.; Patel, P.; Selby, P.J.; Banks, R.E. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 2004, 4, 4019-4031.
132. Xiao, D.; Ohlendorf, J.; Chen, Y.; Taylor, D.D.; Rai, S.N.; Waigel, S.; Zacharias, W.; Hao, H.; McMasters, K.M. Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One 2012, 7, e46874.
133. Drust, D.S.; Creutz, C.E. Aggregation of chromaffin granules by calpactin at micromolar levels of calcium. Nature 1988, 331, 88-91.
134. Thiel, C.; Osborn, M.; Gerke, V. The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11-and Ca(2+)-binding sites. J. Cell Sci. 1992, 103 (Pt. 3), 733-742.
135. Zokas, L.; Glenney, J.R., Jr. The calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: Studies using monoclonal antibodies to calpactin subunits. J. Cell Biol. 1987, 105, 2111-2121.
136. Umbrecht-Jenck, E.; Demais, V.; Calco, V.; Bailly, Y.; Bader, M.F.; Chasserot-Golaz, S. S100A10-mediated translocation of annexin-A2 to SNARE proteins in adrenergic chromaffin cells undergoing exocytosis. Traffic 2010, 11, 958-971.
137. Babbin, B.A.; Parkos, C.A.; Mandell, K.J.; Winfree, L.M.; Laur, O.; Ivanov, A.I.; Nusrat, A. Annexin 2 regulates intestinal epithelial cell spreading and wound closure through Rho-related signaling. Am. J. Pathol. 2007, 170, 951-966.
138. Barwe, S.P.; Anilkumar, G.; Moon, S.Y.; Zheng, Y.; Whitelegge, J.P.; Rajasekaran, S.A.; Rajasekaran, A.K. Novel role for Na, K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol. Biol. Cell 2005, 16, 1082-1094.
139. Hall, A. G proteins and small GTPases: Distant relatives keep in touch. Science 1998, 280, 2074-2075.
140. Tapon, N.; Hall, A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 1997, 9, 86-92.
141. Yamada, A.; Irie, K.; Hirota, T.; Ooshio, T.; Fukuhara, A.; Takai, Y. Involvement of the annexin II-S100A10 complex in the formation of E-cadherin-based adherens junctions in Madin-Darby canine kidney cells. J. Biol. Chem. 2005, 280, 6016-6027.
142. Su, S.C.; Maxwell, S.A.; Bayless, K.J. Annexin 2 regulates endothelial morphogenesis by controlling AKT activation and junctional integrity. J. Biol. Chem. 2010, 285, 40624-40634.
143. Lee, D.B.; Jamgotchian, N.; Allen, S.G.; Kan, F.W.; Hale, I.L. Annexin A2 heterotetramer: Role in tight junction assembly. Am. J. Physiol. Renal Physiol. 2004, 287, F481-F491.
144. Krishna, P.; Kennedy, B.P.; Waisman, D.M.; van de Sande, J.H.; McGhee, J.D. Are many Z-DNA binding proteins actually phospholipid-binding proteins? Proc. Natl. Acad. Sci. USA 1990, 87, 1292-1295.
145. Vedeler, A.; Hollas, H. Annexin II is associated with mRNAs which may constitute a distinct subpopulation. Biochem. J. 2000, 348 Pt. 3, 565-572.
146. Aukrust, I.; Hollas, H.; Strand, E.; Evensen, L.; Trave, G.; Flatmark, T.; Vedeler, A. The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV. J. Mol. Biol. 2007, 368, 1367-1378.
147. Mickleburgh, I.; Burtle, B.; Hollas, H.; Campbell, G.; Chrzanowska-Lightowlers, Z.; Vedeler, A.; Hesketh, J. Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA. FEBS J. 2005, 272, 413-421.
148. Bassell, G.; Singer, R.H. mRNA and cytoskeletal filaments. Curr. Opin. Cell Biol. 1997, 9, 109-115.
149. Miles, L.A.; Plow, E.F.; Waisman, D.M.; Parmer, R.J. Plasminogen receptors. J. Biomed. Biotechnol. 2012, 2012, 130735.
150. Ellis, V.; Behrendt, N.; Dano, K. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 1991, 266, 12752-12758.
151. Plow, E.F.; Freaney, D.E.; Plescia, J.; Miles, L.A. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type. J. Cell Biol. 1986, 103, 2411-2420.
152. Felez, J.; Miles, L.A.; Fabregas, P.; Jardi, M.; Plow, E.F.; Lijnen, R.H. Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells. Thromb. Haemost. 1996, 76, 577-584.
153. Hajjar, K.A.; Jacovina, A.T.; Chacko, J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem. 1994, 269, 21191-21197.
154. O'Connell, P.A.; Surette, A.P.; Liwski, R.S.; Svenningsson, P.; Waisman, D.M. S100A10 regulates plasminogen-dependent macrophage invasion. Blood 2010, 116, 1136-1146.
155. MacLeod, T.J.; Kwon, M.; Filipenko, N.R.; Waisman, D.M. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: Characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J. Biol. Chem. 2003, 278, 25577-25584.
156. Das, R.; Burke, T.; Plow, E.F. Histone H2B as a functionally important plasminogen receptor on macrophages. Blood 2007, 110, 3763-3772.
157. Roda, O.; Valero, M.L.; Peiro, S.; Andreu, D.; Real, F.X.; Navarro, P. New insights into the tPA-annexin A2 interaction. Is annexin A2 CYS8 the sole requirement for this association? J. Biol. Chem. 2003, 278, 5702-5709.
158. Felez, J.; Chanquia, C.J.; Fabregas, P.; Plow, E.F.; Miles, L.A. Competition between plasminogen and tissue plasminogen activator for cellular binding sites. Blood 1993, 82, 2433-2441.
159. Felez, J.; Chanquia, C.J.; Levin, E.G.; Miles, L.A.; Plow, E.F. Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Blood 1991, 78, 2318-2327.
160. Beebe, D.P.; Miles, L.A.; Plow, E.F. A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor. Blood 1989, 74, 2034-2037.
161. Sinniger, V.; Merton, R.E.; Fabregas, P.; Felez, J.; Longstaff, C. Regulation of tissue plasminogen activator activity by cells. Domains responsible for binding and mechanism of stimulation. J. Biol. Chem. 1999, 274, 12414-12422.
162. Suzuki, Y.; Mogami, H.; Ihara, H.; Urano, T. Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells. Blood 2009, 113, 470-478.
163. Byeon, I.J.; Llinas, M. Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug. J. Mol. Biol. 1991, 222, 1035-1051.
164. Galantai, R.; Modos, K.; Fidy, J.; Kolev, K.; Machovich, R. Structural basis of the cofactor function of denatured albumin in plasminogen activation by tissue-type plasminogen activator. Biochem. Biophys. Res. Commun. 2006, 341, 736-741.
165. Novokhatny, V.V.; Ingham, K.C.; Medved, L.V. Domain structure and domain-domain interactions of recombinant tissue plasminogen activator. J. Biol. Chem. 1991, 266, 12994-13002.
166. Kassam, G.; Choi, K.S.; Ghuman, J.; Kang, H.M.; Fitzpatrick, S.L.; Zackson, T.; Zackson, S.; Toba, M.; Shinomiya, A.; Waisman, D.M. The role of annexin II tetramer in the activation of plasminogen. J. Biol. Chem. 1998, 273, 4790-4799.
167. Nilius, B.; Gerke, V.; Prenen, J.; Szucs, G.; Heinke, S.; Weber, K.; Droogmans, G. Annexin II modulates volume-activated chloride currents in vascular endothelial cells. J. Biol. Chem. 1996, 271, 30631-30636.
168. Chetcuti, A.; Margan, S.H.; Russell, P.; Mann, S.; Millar, D.S.; Clark, S.J.; Rogers, J.; Handelsman, D.J.; Dong, Q. Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res. 2001, 61, 6331-6334.
169. Zobiack, N.; Rescher, U.; Ludwig, C.; Zeuschner, D.; Gerke, V. The annexin 2/S100A10 complex controls the distribution of transferrin receptor-containing recycling endosomes. Mol. Biol. Cell 2003, 14, 4896-4908.
170. Choi, K.S.; Fogg, D.K.; Yoon, C.S.; Waisman, D.M. p11 regulates extracellular plasmin production and invasiveness of HT1080 fibrosarcoma cells. FASEB J. 2003, 17, 235-246.
171. Surette, A.P.; Madureira, P.A.; Phipps, K.D.; Miller, V.A.; Svenningsson, P.; Waisman, D.M. Regulation of fibrinolysis by S100A10 in vivo. Blood 2011, 118, 3172-3181.
172. Ling, Q.; Jacovina, A.T.; Deora, A.; Febbraio, M.; Simantov, R.; Silverstein, R.L.; Hempstead, B.; Mark, W.H.; Hajjar, K.A. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J. Clin. Invest. 2004, 113, 38-48.
173. Brownstein, C.; Deora, A.B.; Jacovina, A.T.; Weintraub, R.; Gertler, M.; Khan, K.M.; Falcone, D.J.; Hajjar, K.A. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: Enhanced expression by macrophages. Blood 2004, 103, 317-324.
174. Falcone, D.J.; Borth, W.; Khan, K.M.; Hajjar, K.A. Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 2001, 97, 777-784.
175. Gou, D.; Mishra, A.; Weng, T.; Su, L.; Chintagari, N.R.; Wang, Z.; Zhang, H.; Gao, L.; Wang, P.; Stricker, H.M.; Liu, L. Annexin A2 interactions with Rab14 in alveolar type II cells. J. Biol. Chem. 2008, 283, 13156-13164.
176. Gong, Y.; Hart, E.; Shchurin, A.; Hoover-Plow, J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J. Clin. Invest. 2008, 118, 3012-3024.
177. Mai, J.; Finley, R.L., Jr.; Waisman, D.M.; Sloane, B.F. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 2000, 275, 12806-12812.
178. McColl, B.K.; Baldwin, M.E.; Roufail, S.; Freeman, C.; Moritz, R.L.; Simpson, R.J.; Alitalo, K.; Stacker, S.A.; Achen, M.G. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J. Exp. Med. 2003, 198, 863-868.
179. Chiang, Y.; Schneiderman, M.H.; Vishwanatha, J.K. Annexin II expression is regulated during mammalian cell cycle. Cancer Res. 1993, 53, 6017-6021.
180. Sharma, M.R.; Rothman, V.; Tuszynski, G.P.; Sharma, M.C. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: Possible biochemical mechanism of angiostatin's action. Exp. Mol. Pathol. 2006, 81, 136-145.
181. Tuszynski, G.P.; Sharma, M.R.; Rothman, V.L.; Sharma, M.C. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells. Microvasc. Res. 2002, 64, 448-462.
182. Sharma, M.; Ownbey, R.T.; Sharma, M.C. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp. Mol. Pathol. 2010, 88, 278-286.
183. Oskarsson, T.; Acharyya, S.; Zhang, X.H.; Vanharanta, S.; Tavazoie, S.F.; Morris, P.G.; Downey, R.J.; Manova-Todorova, K.; Brogi, E.; Massague, J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 2011, 17, 867-874.
184. Chuthapisith, S.; Layfield, R.; Kerr, I.D.; Hughes, C.; Eremin, O. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int. J. Oncol. 2007, 30, 1545-1551.
185. Esposito, I.; Penzel, R.; Chaib-Harrireche, M.; Barcena, U.; Bergmann, F.; Riedl, S.; Kayed, H.; Giese, N.; Kleeff, J.; Friess, H.; Schirmacher, P. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J. Pathol. 2006, 208, 673-685.
186. Sitek, B.; Sipos, B.; Alkatout, I.; Poschmann, G.; Stephan, C.; Schulenborg, T.; Marcus, K.; Luttges, J.; Dittert, D.D.; Baretton, G.; et al. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. J. Proteome Res. 2009, 8, 1647-1656.
187. Diaz, V.M.; Hurtado, M.; Thomson, T.M.; Reventos, J.; Paciucci, R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 2004, 53, 993-1000.
188. Tian, R.; Wei, L.M.; Qin, R.Y.; Li, Y.; Du, Z.Y.; Xia, W.; Shi, C.J.; Jin, H. Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins. Dig. Dis. Sci. 2008, 53, 65-72.
189. Chung, C.Y.; Murphy-Ullrich, J.E.; Erickson, H.P. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol. Biol. Cell 1996, 7, 883-892.
190. Takano, S.; Togawa, A.; Yoshitomi, H.; Shida, T.; Kimura, F.; Shimizu, H.; Yoshidome, H.; Ohtsuka, M.; Kato, A.; Tomonaga, T.; et al. Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy. Ann. Surg. Oncol. 2008, 15, 3157-3168.
191. Domoto, T.; Miyama, Y.; Suzuki, H.; Teratani, T.; Arai, K.; Sugiyama, T.; Takayama, T.; Mugiya, S.; Ozono, S.; Nozawa, R. Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci. 2007, 98, 77-82.
192. Ohno, Y.; Izumi, M.; Kawamura, T.; Nishimura, T.; Mukai, K.; Tachibana, M. Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br. J. Cancer 2009, 101, 287-294.
193. Emoto, K.; Yamada, Y.; Sawada, H.; Fujimoto, H.; Ueno, M.; Takayama, T.; Kamada, K.; Naito, A.; Hirao, S.; Nakajima, Y. Annexin II overexpression correlates with stromal tenascin-C overexpression: A prognostic marker in colorectal carcinoma. Cancer 2001, 92, 1419-1426.
194. Pei, H.; Zhu, H.; Zeng, S.; Li, Y.; Yang, H.; Shen, L.; Chen, J.; Zeng, L.; Fan, J.; Li, X.; et al. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J. Proteome Res. 2007, 6, 2495-2501.
195. Zhang, L.; Fogg, D.K.; Waisman, D.M. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J. Biol. Chem. 2004, 279, 2053-2062.
196. Giraldez, M.D.; Lozano, J.J.; Cuatrecasas, M.; Alonso-Espinaco, V.; Maurel, J.; Marmol, M.; Horndler, C.; Ortego, J.; Alonso, V.; Escudero, P.; et al. Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5' fluoruracil-based adjuvant chemotherapy. Int. J. Cancer 2013, 132, 1090-1097.
197. Frohlich, M.; Motte, P.; Galvin, K.; Takahashi, H.; Wands, J.; Ozturk, M. Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol. Cell. Biol. 1990, 10, 3216-3223.
198. Swisher, J.F.; Khatri, U.; Feldman, G.M. Annexin A2 is a soluble mediator of macrophage activation. J. Leukoc. Biol. 2007, 82, 1174-1184.
199. Mohammad, H.S.; Kurokohchi, K.; Yoneyama, H.; Tokuda, M.; Morishita, A.; Jian, G.; Shi, L.; Murota, M.; Tani, J.; Kato, K.; et al. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int. J. Oncol. 2008, 33, 1157-1163.
200. Longerich, T.; Haller, M.T.; Mogler, C.; Aulmann, S.; Lohmann, V.; Schirmacher, P.; Brand, K. Annexin A2 as a differential diagnostic marker of hepatocellular tumors. Pathol. Res. Pract. 2011, 207, 8-14.
201. Kittaka, N.; Takemasa, I.; Takeda, Y.; Marubashi, S.; Nagano, H.; Umeshita, K.; Dono, K.; Matsubara, K.; Matsuura, N.; Monden, M. Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. Eur. J. Cancer 2008, 44, 885-897.
202. Sun, Y.; Gao, G.; Cai, J.; Wang, Y.; Qu, X.; He, L.; Liu, F.; Zhang, Y.; Lin, K.; Ma, S.; et al. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma. Carcinogenesis 2013, 34, 595-604.
203. Menell, J.S.; Cesarman, G.M.; Jacovina, A.T.; McLaughlin, M.A.; Lev, E.A.; Hajjar, K.A. Annexin II and bleeding in acute promyelocytic leukemia. N. Engl. J. Med. 1999, 340, 994-1004.
204. Liu, Y.; Wang, Z.; Jiang, M.; Dai, L.; Zhang, W.; Wu, D.; Ruan, C. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia. Leuk. Res. 2011, 35, 879-884.
205. O'Connell, P.A.; Madureira, P.A.; Berman, J.N.; Liwski, R.S.; Waisman, D.M. Regulation of S100A10 by the PML-RAR-alpha oncoprotein. Blood 2011, 117, 4095-4105.
206. Zhao, W.; Wang, X.; Guo, W.; Qu, B.; Wang, H.; Shen, Z.; Chen, Z.; Wang, Z. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment. Chin. Med. J. (Engl.) 2000, 113, 236-240.
207. Xie, Y.; Wang, Z.Y.; Zhang, W.; Dai, L.; Bai, X. The fibrinolytic activity in leukemic cell lines and its alteration on all-trans retinoic acid treatment (in Chinese). Zhonghua Xue Ye Xue Za Zhi 2006, 27, 588-592.
208. Zhang, X.H.; Hu, Y.; Bao, L.; Jiang, Q.; Yang, L.H.; Lu, X.J.; Hong, M.; Xia, L.H.; Guo, T.; Shen, G.X.; et al. Arsenic trioxide downregulates the expression of annexin II in bone marrow cells from patients with acute myelogenous leukemia. Chin. Med. J. (Engl.) 2009, 122, 1969-1973.
209. Yee, D.S.; Narula, N.; Ramzy, I.; Boker, J.; Ahlering, T.E.; Skarecky, D.W.; Ornstein, D.K. Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Arch. Pathol. Lab. Med. 2007, 131, 902-908.
210. Xin, W.; Rhodes, D.R.; Ingold, C.; Chinnaiyan, A.M.; Rubin, M.A. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am. J. Pathol. 2003, 162, 255-261.
211. Banerjee, A.G.; Liu, J.; Yuan, Y.; Gopalakrishnan, V.K.; Johansson, S.L.; Dinda, A.K.; Gupta, N.P.; Trevino, L.; Vishwanatha, J.K. Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA. Mol. Cancer 2003, 2, 34.
212. Inokuchi, J.; Narula, N.; Yee, D.S.; Skarecky, D.W.; Lau, A.; Ornstein, D.K.; Tyson, D.R. Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells. Int. J. Cancer 2009, 124, 68-74.
213. Shiozawa, Y.; Havens, A.M.; Jung, Y.; Ziegler, A.M.; Pedersen, E.A.; Wang, J.; Lu, G.; Roodman, G.D.; Loberg, R.D.; Pienta, K.J.; et al. Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J. Cell. Biochem. 2008, 105, 370-380.
214. Qi, Y.J.; Wang, L.D.; Jiao, X.Y.; Feng, X.S.; Fan, Z.M.; Gao, S.S.; He, X.; Li, J.L.; Chang, F.B. Dysregulation of Annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province (in Chinese). Ai Zheng 2007, 26, 730-736.
215. Chan, C.M.; Wong, S.C.; Lam, M.Y.; Hui, E.P.; Chan, J.K.; Lo, E.S.; Cheuk, W.; Wong, M.C.; Tsao, S.W.; Chan, A.T. Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma. Arch. Pathol. Lab. Med. 2008, 132, 675-683.
216. Pena-Alonso, E.; Rodrigo, J.P.; Parra, I.C.; Pedrero, J.M.; Meana, M.V.; Nieto, C.S.; Fresno, M.F.; Morgan, R.O.; Fernandez, M.P. Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett. 2008, 263, 89-98.
217. Wu, W.; Tang, X.; Hu, W.; Lotan, R.; Hong, W.K.; Mao, L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin. Exp. Metastasis 2002, 19, 319-326.
218. Kesavan, K.; Ratliff, J.; Johnson, E.W.; Dahlberg, W.; Asara, J.M.; Misra, P.; Frangioni, J.V.; Jacoby, D.B. Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. J. Biol. Chem. 2010, 285, 4366-4374.
219. Braden, A.R.; Kafka, M.T.; Cunningham, L.; Jones, H.; Vishwanatha, J.K. Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth. J. Nanosci. Nanotechnol. 2009, 9, 2856-2865.
220. Song, C.; Zhou, X.; Dong, Q.; Fan, R.; Wu, G.; Ji, B.; Meng, Q.; Zheng, M. Regulation of inflammatory response in human chondrocytes by lentiviral mediated RNA interference against S100A10. Inflamm. Res. 2012, 61, 1219-1227.
221. Lin, L.; Wu, C.; Hu, K. Tissue plasminogen activator activates NF-kappaB through a pathway involving annexin A2/CD11b and integrin-linked kinase. J. Am. Soc. Nephrol. 2012, 23, 1329-1338.
222. Laumonnier, Y.; Syrovets, T.; Burysek, L.; Simmet, T. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood 2006, 107, 3342-3349.
223. Li, Q.; Laumonnier, Y.; Syrovets, T.; Simmet, T. Plasmin triggers cytokine induction in human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1383-1389.
224. He, K.L.; Sui, G.; Xiong, H.; Broekman, M.J.; Huang, B.; Marcus, A.J.; Hajjar, K.A. Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2. J. Biol. Chem. 2011, 286, 15428-15439.
225. Singh, P.; Wu, H.; Clark, C.; Owlia, A. Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells. Oncogene 2007, 26, 425-440.
226. Sarkar, S.; Swiercz, R.; Kantara, C.; Hajjar, K.A.; Singh, P. Annexin A2 mediates up-regulation of NF-kappaB, beta-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Gastroenterology 2011, 140, 583-595 e584.
227. Sarkar, S.; Kantara, C.; Singh, P. Clathrin mediates endocytosis of progastrin and activates MAPKs: Role of cell surface annexin A2. Am. J. Physiol. Gastrointest Liver Physiol. 2012, 302, G712-722.
228. Swisher, J.F.; Burton, N.; Bacot, S.M.; Vogel, S.N.; Feldman, G.M. Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 2010, 115, 549-558.
229. Li, F.; Chung, H.; Reddy, S.V.; Lu, G.; Kurihara, N.; Zhao, A.Z.; Roodman, G.D. Annexin II stimulates RANKL expression through MAPK. J. Bone Miner. Res. 2005, 20, 1161-1167.
230. Menaa, C.; Devlin, R.D.; Reddy, S.V.; Gazitt, Y.; Choi, S.J.; Roodman, G.D. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J. Clin. Invest. 1999, 103, 1605-1613.
231. Bouma, B.; de Groot, P.G.; van den Elsen, J.M.; Ravelli, R.B.; Schouten, A.; Simmelink, M.J.; Derksen, R.H.; Kroon, J.; Gros, P. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J. 1999, 18, 5166-5174.
232. Schwarzenbacher, R.; Zeth, K.; Diederichs, K.; Gries, A.; Kostner, G.M.; Laggner, P.; Prassl, R. Crystal structure of human beta2-glycoprotein I: Implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 1999, 18, 6228-6239.
233. Ma, K.; Simantov, R.; Zhang, J.C.; Silverstein, R.; Hajjar, K.A.; McCrae, K.R. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J. Biol. Chem. 2000, 275, 15541-15548.
234. Zhang, J.; McCrae, K.R. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 2005, 105, 1964-1969.
235. Cesarman-Maus, G.; Rios-Luna, N.P.; Deora, A.B.; Huang, B.; Villa, R.; Cravioto Mdel, C.; Alarcon-Segovia, D.; Sanchez-Guerrero, J.; Hajjar, K.A. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood 2006, 107, 4375-4382.
236. Cockrell, E.; Espinola, R.G.; McCrae, K.R. Annexin A2: Biology and relevance to the antiphospholipid syndrome. Lupus 2008, 17, 943-951.
237. Allen, K.L.; Fonseca, F.V.; Betapudi, V.; Willard, B.; Zhang, J.; McCrae, K.R. A novel pathway for human endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 2012, 119, 884-893.